ms CLAUDIA SCHLOSBERG — Lobbyist Profile | Poliscope

ms CLAUDIA SCHLOSBERG

Reported covered position: N/A

Filings

Clients

Firms

Years active

2007–2011

Associated filing income

$220,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
ADVANCED CLINICAL CONSULTANTS LLC	3	2007
COVENANT PHARMACY, LLC	3	2010–2011
EXCELLERX INC	3	2007
FOREST LABORATORIES INC	3	2007
FORUM EXTENDED CARE SERVICES	3	2010–2011
MCNEILL'S LONG TERM CARE PHARMACY	3	2010–2011

Lobbying firms

Firm	Filings	Years
CLAUDIA SCHLOSBERG	21	2007–2011

Bills explicitly cited in this lobbyist’s assigned issues (7)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 2900

Food and Drug Administration Amendments Act of 2007

Client: FOREST LABORATORIES INC · Firm: CLAUDIA SCHLOSBERG

Open original LDA filing ↗

Cited source text

H.R. 2900 Prescription Drug User Fee Authorization Act (treatment of certain enantiomer drugs; S. 1082 FDA Revitalization Act, Sec. 264 (treatment of certain enantiomer drugs; re-importation.

H.R. 2900

Food and Drug Administration Amendments Act of 2007

Client: FOREST LABORATORIES INC · Firm: CLAUDIA SCHLOSBERG

Open original LDA filing ↗

Cited source text

H.R. 2900, Prescription Drug User Fee Reauthorization Act, (treatment of certain enantiomer drugs; S. 1082, FDA Revitalization Act, Sec. 264, (treatment of certain enantiomer drugs).

Original LDA source filings (21)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

PHARMACY CARE ASSOCIATES via CLAUDIA SCHLOSBERG

2011 · first_quarter · 1T

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

Controlled Substances Act

Filing targets: SENATE

MCNEILL'S LONG TERM CARE PHARMACY via CLAUDIA SCHLOSBERG

2011 · first_quarter · 1T

Firm income: —Client expense: —Open original LDA filing ↗

Source: Senate LDA

Show 17 more original filings

COVENANT PHARMACY, LLC via CLAUDIA SCHLOSBERG

2010 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

Controlled Substances Act

Filing targets: SENATE

PHARMACY CARE ASSOCIATES via CLAUDIA SCHLOSBERG

2010 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

Controlled Substances Act

Filing targets: SENATE

MCNEILL'S LONG TERM CARE PHARMACY via CLAUDIA SCHLOSBERG

2010 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

Controlled Substances Act

Filing targets: SENATE

FORUM EXTENDED CARE SERVICES via CLAUDIA SCHLOSBERG

2010 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

Controlled Substances Act

Filing targets: SENATE

PHARMACY CARE ASSOCIATES via CLAUDIA SCHLOSBERG

2010 · fourth_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

GOV

Government Issues

Controlled Substances Act

PHA

Pharmacy

Controlled Substances Act

MCNEILL'S LONG TERM CARE PHARMACY via CLAUDIA SCHLOSBERG

2010 · fourth_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

PHA

Pharmacy

Controlled Substances Act

GOV

Government Issues

Controlled Substances Act

COVENANT PHARMACY, LLC via CLAUDIA SCHLOSBERG

2010 · fourth_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

PHA

Pharmacy

Controlled Substances Act

GOV

Government Issues

Controlled Substances Act

FORUM EXTENDED CARE SERVICES via CLAUDIA SCHLOSBERG

2010 · fourth_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

GOV

Government Issues

Controlled Substances Act

PHA

Pharmacy

Controlled Substances Act

ADVANCED CLINICAL CONSULTANTS LLC via CLAUDIA SCHLOSBERG

2007 · year_end · YT

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Health Information Technology for Low-Income Communities S. 1678, Home Health Care Planning Improvement Act

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FOREST LABORATORIES INC via CLAUDIA SCHLOSBERG

2007 · year_end · YT

Firm income: $160,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

H.R. 2900 Prescription Drug User Fee Authorization Act (treatment of certain enantiomer drugs; S. 1082 FDA Revitalization Act, Sec. 264 (treatment of certain enantiomer drugs; re-importation.

MMM

Medicare/Medicaid

H.R. 3025, Medicre Prescription Drug Savings for Our Seniors Act of 2007, Sec. 505, COverage of mental health drugs under Medicare Part D; H.R. 3162, Children's Health and Medicare Protections Act of 2007, Sec. 225, Coverage of mental health drugs under Medicare part D; S.3 Access to Critical Medications under Medicate Part D.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

EXCELLERX INC via CLAUDIA SCHLOSBERG

2007 · year_end · YT

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

Medication therapy management; E-prescribing and Controlled Substances

Filing targets: Drug Enforcement Administration (DEA), Health & Human Services, Dept of (HHS), SENATE

EXCELLERX INC via CLAUDIA SCHLOSBERG

2007 · mid_year · MM

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

Medication therapy management; e-prescribing

Filing targets: Drug Enforcement Administration (DEA), Health & Human Services, Dept of (HHS), SENATE

FOREST LABORATORIES INC via CLAUDIA SCHLOSBERG

2007 · mid_year · MM

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MMM

Medicare/Medicaid

H.R. 3025, Medicare Prescription Drug Savings for Our Seniors Act of 2007, Sec. 505, Coverage of mental health drugs under Medicare part D;, H.R. 3162, Children's Health and Medicare Protection Act of 2007, Sec. 225, Coverage of mental health drugs under Medicare Part D; S.3 Access to Critical Medications under Medicare Part D.

HCR

Health Issues

H.R. 2900, Prescription Drug User Fee Reauthorization Act, (treatment of certain enantiomer drugs; S. 1082, FDA Revitalization Act, Sec. 264, (treatment of certain enantiomer drugs).

Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

ADVANCED CLINICAL CONSULTANTS LLC via CLAUDIA SCHLOSBERG

2007 · mid_year · MM

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Health Information Technology for low-income communities Medical Assistance for seniors returning to New Orleans after Katrina

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FOREST LABORATORIES INC via CLAUDIA SCHLOSBERG

2007 · year_end · RR

Firm income: —Client expense: —Open original LDA filing ↗